Table 2.
Strains tested, their geographic origins, and test resultsa
| Clonal complex | Strain | Total no. | No. PVL positive in lateral flow assay | No. PVL negative in lateral flow assay | No. of isolates from: |
No. of reference strains | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia | Germany | Saudi Arabia | Spain | Sweden | Trinidad and Tobago | Uganda | United Kingdom: London | United Kingdom: Bristol | ||||||
| CC1 | CC1-MSSA | 7 | 7 | 3 | 1 | 2 | 1 | |||||||
| CC1-MSSA (PVL+) | 6 | 6 | 1 | 1 | 1 | 2 | 1 | |||||||
| CC1-MSSA-SCCfus | 8 | 8 | 2 | 1 | 1 | 2 | 1 | 1 | ||||||
| CC1-MSSA-SCCfus (PVL+) | 7 | 7 | 4 | 3 | ||||||||||
| CC1-MRSA-IV, WA-MRSA-1/57 | 1 | 1 | 1 | |||||||||||
| CC1-MRSA-IV (PVL+), USA400 | 3 | 3 | 1 | 1 | 1 | |||||||||
| CC1-MRSA-IV&SCCfus, WA-1/45 | 1 | 1 | 1 | |||||||||||
| CC1 (ST573/772) | ST573/772-MSSA (PVL+) | 2 | 2 | 2 | ||||||||||
| ST772-MRSA-V (PVL+), Bengal Bay clone/WA-60 | 4 | 4 | 2 | 1 | 1 | |||||||||
| CC5 | CC5-MSSA | 10 | 10 | 1 | 1 | 6 | 2 | |||||||
| CC5-MSSA (PVL+) | 8 | 8 | 1 | 1 | 5 | 1 | ||||||||
| CC5-MRSA-II, UK-3/Rhine-Hesse/New York Japan | 3 | 3 | 1 | 2 | ||||||||||
| CC5-MRSA-IV, Pediatric clone | 1 | 1 | 1 | |||||||||||
| CC5-MRSA-IV (edinA+), WA-65 | 1 | 1 | 1 | |||||||||||
| CC5-MRSA-IV, Pediatric clone (PVL+) | 5 | 5 | 2 | 3 | ||||||||||
| CC5-MRSA-IVvar, Maltese clone | 1 | 1 | 1 | |||||||||||
| CC5-MRSA-V (PVL+) | 1 | 1 | 1 | |||||||||||
| CC6 | CC6-MSSA | 3 | 3 | 1 | 2 | |||||||||
| CC7 | CC7-MSSA | 9 | 9 | 1 | 1 | 5 | 2 | |||||||
| CC7-MRSA-IV | 1 | 1 | 1 | |||||||||||
| CC8 | CC8-MSSA | 41 | 3* | 38 | 2 | 6 | 1 | 3 | 5 | 21 | 2 | 1 | ||
| CC8-MSSA (PVL+) | 23 | 23 | 2 | 1 | 18 | 2 | ||||||||
| CC8-MSSA-SCCfus | 1 | 1 | 1 | |||||||||||
| ST250-MRSA-I, Early/Ancestral MRSA | 1 | 1 | 1 | |||||||||||
| CC8-MRSA-IV, WA-62 | 2 | 2 | 2 | |||||||||||
| ST8-MRSA-IV (PVL+/ACME+), USA300 | 10 | 10 | 2 | 1 | 3 | 3 | 1 | |||||||
| ST8-MRSA-IV (PVL+/ACME−) | 10 | 10 | 10 | |||||||||||
| CC8 (ST72) | ST72-MSSA | 13 | 13 | 2 | 1 | 1 | 7 | 2 | ||||||
| ST72-MSSA (PVL+) | 1 | 1 | 1 | |||||||||||
| CC8 (ST239) | ST239-MRSA-III, Vienna/Hungarian/Brazilian clone | 13 | 13 | 5 | 6 | 1 | 1 | |||||||
| CC9 (ST834) | ST834-MSSA | 2 | 2 | 2 | ||||||||||
| ST834-MRSA-VI | 1 | 1 | 1 | |||||||||||
| CC12 | CC12-MSSA | 8 | 8 | 5 | 1 | 2 | ||||||||
| CC12-MRSA, WA-59 | 1 | 1 | 1 | |||||||||||
| CC15 | CC15-MSSA | 29 | 1* | 28 | 2 | 1 | 3 | 1 | 18 | 2 | 2 | |||
| CC15-MSSA (PVL+) | 2 | 2 | 1 | 1 | ||||||||||
| CC20 | CC20-MSSA | 3 | 3 | 3 | ||||||||||
| CC22 | CC22-MSSA | 6 | 1* | 5 | 3 | 1 | 1 | 1 | ||||||
| CC22-MSSA (PVL+) | 19 | 19 | 2 | 2 | 5 | 10 | ||||||||
| CC22-MSSA-SCCfus (PVL+) | 5 | 5 | 5 | |||||||||||
| CC22-MRSA-IV, UK-EMRSA-15/Barnim EMRSA | 4 | 4 | 1 | 1 | 1 | 1 | ||||||||
| CC22-MRSA-IV (PVL+) | 5 | 5 | 2 | 1 | 2 | |||||||||
| CC25 | CC25-MSSA | 10 | 10 | 3 | 6 | 1 | ||||||||
| CC25-MSSA (PVL+) | 2 | 2 | 2 | |||||||||||
| CC30 | CC30-MSSA | 20 | 20 | 1 | 8 | 3 | 7 | 1 | ||||||
| CC30-MSSA (PVL+) | 35 | 34 | 1* | 3 | 4 | 4 | 6 | 4 | 10 | 1 | 2 | 1 | ||
| CC30-MRSA-IV (PVL+), Southwest Pacific CA-MRSA clone | 11 | 11 | 5 | 1 | 1 | 4 | ||||||||
| CC30 (ST34) | ST34-MSSA | 5 | 5 | 1 | 1 | 1 | 2 | |||||||
| CC45 | CC45-MSSA | 33 | 33 | 2 | 4 | 1 | 2 | 19 | 2 | 3 | ||||
| CC45-MSSA (PVL+) | 2 | 2 | 1 | 1 | ||||||||||
| CC45-MRSA-IV, Berlin EMRSA | 1 | 1 | 1 | |||||||||||
| CC49 | ST49-MSSA (PVL+) | 1 | 1 | 1 | ||||||||||
| CC50 | CC50-MSSA | 3 | 3 | 3 | ||||||||||
| CC59 | CC59-MSSA | 1 | 1 | 1 | ||||||||||
| CC59-MSSA (PVL+) | 1 | 1 | 1 | |||||||||||
| CC59-MRSA-V | 1 | 1 | 1 | |||||||||||
| CC59-MRSA-V (PVL+) | 1 | 1 | 1 | |||||||||||
| ST59/ST952-MRSA-V(T) (PVL+), Taiwan CA-MRSA clone | 3 | 3 | 1 | 2 | ||||||||||
| CC59-MRSA-V&SCCfus | 2 | 2 | 2 | |||||||||||
| CC75 | MSSA, related to ST1223 | 2 | 2 | 2 | ||||||||||
| MSSA, related to ST1667 | 2 | 2 | 1 | 1 | ||||||||||
| ST75-MRSA-IV, WA-MRSA-8/79 | 1 | 1 | 1 | |||||||||||
| CC80 | CC80-MSSA (PVL+) | 5 | 5 | 1 | 1 | 2 | 1 | |||||||
| CC80-MRSA-IV | 2 | 2 | 2 | |||||||||||
| CC80-MRSA-IV (PVL+), European CA-MRSA clone | 13 | 13 | 11 | 2 | ||||||||||
| CC88 | CC88-MSSA | 2 | 2 | 1 | 1 | |||||||||
| CC88-MSSA (PVL+) | 2 | 2 | 2 | |||||||||||
| CC88-MRSA-IV (PVL+) | 2 | 2 | 2 | |||||||||||
| CC93 | ST93-MSSA (PVL+) | 9 | 9 | 9 | ||||||||||
| ST93-MRSA-IV (PVL+), Queensland CA-MRSA clone | 33 | 33 | 30 | 1 | 1 | 1 | ||||||||
| CC96 | CC96/154-MSSA | 1 | 1 | 1 | ||||||||||
| CC96/154-MSSA (PVL+) | 1 | 1 | 1 | |||||||||||
| CC97 | CC97-MSSA | 8 | 8 | 1 | 7 | |||||||||
| CC101 | CC101-MSSA | 3 | 3 | 1 | 1 | 1 | ||||||||
| CC121 | CC121-MSSA | 16 | 16 | 2 | 8 | 4 | 1 | 1 | ||||||
| CC121-MSSA (PVL+) | 50 | 50 | 15 | 8 | 4 | 3 | 17 | 2 | 1 | |||||
| CC140 | CC140-MRSA-IV | 2 | 2 | 2 | ||||||||||
| CC152 | CC152-MSSA (PVL+) | 8 | 8 | 2 | 1 | 2 | 1 | 2 | ||||||
| CC152-MRSA-V (PVL+) | 1 | 1 | 1 | |||||||||||
| CC188 | CC188-MSSA | 6 | 6 | 1 | 1 | 2 | 2 | |||||||
| CC188-MSSA (PVL+) | 2 | 2 | 1 | 1 | ||||||||||
| CC398 | CC398-MSSA | 1 | 1 | 1 | ||||||||||
| CC398-MSSA (PVL+) | 1 | 1 | 1 | |||||||||||
| CC398 (ST291/813) | ST291/813-MSSA | 1 | 1 | 1 | ||||||||||
| ST291/813-MSSA (PVL+) | 1 | 1 | 1 | |||||||||||
| CC425 | ST425-MRSA-XI | 1 | 1 | 1 | ||||||||||
| CC509 | CC509-MSSA | 1 | 1 | 1 | ||||||||||
| CC707 | ST707-MSSA | 1 | 1 | 1 | ||||||||||
| CC1021 | CC1021-MSSA | 1 | 1 | 1 | ||||||||||
| CC1290 | CC1290/ST2481-MSSA | 1 | 1 | 1 | ||||||||||
| ST2479 | ST2479-MSSA (PVL+) | 1 | 1 | 1 | ||||||||||
| ST2482 | ST2482-MSSA (PVL+) | 4 | 4 | 3 | 1 | |||||||||
| Unidentified | agr IV/capsule 5 MSSA | 1 | 1 | 1 | ||||||||||
a
Strain assignments were based on array hybridization. False results in lateral flow tests are marked with an asterisk.